financetom
Business
financetom
/
Business
/
Australia's Anson Resources inks lithium carbonate supply deal with LG Energy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australia's Anson Resources inks lithium carbonate supply deal with LG Energy
Apr 30, 2024 5:43 PM

May 1 (Reuters) - Australia's Anson Resources ( ANSNF )

said on Wednesday it would supply 4,000 dry metric tons of

lithium carbonate per year from its Mexican Paradox Basin

project to South Korean battery giant LG Energy Solution

for an initial term of 5 years.

The commodity lithium has gained quite a traction over the

past few years in tandem with the global trend of transitioning

into green energy with the use of electric vehicles at the

forefront.

However, with diminishing demand of electric vehicles from

China - one of the world's largest EV market - the prices for

lithium, a key ingredient of EV batteries, have fallen quite a

lot in the last few months.

Last month, Mineral Resources, one of Australia's

top lithium producers, held onto its lithium production

expansion plans citing lower lithium prices.

The Paradox Lithium project, owned by the Anson Resources' ( ANSNF )

unit A1 Lithium, has a production capacity of about 10,000 tpa

of battery-grade Lithium Carbonate under phase 1.

The project, which is the company's lead asset, is powered

through hydro and solar energy and will be supplying U.S.-made

lithium to LG Energy.

Last week, LG Energy - a supplier of Tesla and

General Motors ( GM ), among others - had flagged concerns over

a sluggish EV demand and laid out its plans to cut its capital

expenditure for this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australia launches informal review of unannounced Lactalis bid for Fonterra assets
Australia launches informal review of unannounced Lactalis bid for Fonterra assets
May 26, 2025
(Reuters) -Australia's antitrust regulator on Friday began an informal review of Lactalis' proposed bid for Fonterra's assets on the block, even though the French dairy giant has yet to formally announce the offer. Fonterra said in April that some potential buyers were at a stage where they could seek regulatory approvals - a standard step ahead of any deal. In...
Air India allowed to temporarily extend duty, rest for long-haul crew, memo shows
Air India allowed to temporarily extend duty, rest for long-haul crew, memo shows
May 26, 2025
* Pilot duty hours extended to manage Pakistan airspace closure, memo shows * Concerns among pilots over increased workloads amid booming air travel * Permanent solution being worked out, source says By Abhijith Ganapavaram NEW DELHI, May 2 (Reuters) - India's aviation regulator has allowed Air India to temporarily extend the maximum duty hours and rest period for pilots on...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials
AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials
May 26, 2025
May 2 (Reuters) - AstraZeneca ( AZN ) said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for uncontrolled asthma, showing clinically meaningful improvement in lung function. The Anglo-Swedish drugmaker's therapy, already approved for the treatment of Chronic Obstructive Pulmonary Disease or smoker's lung, was being compared with a dual-combination maintenance treatment in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved